Project Lightspeed

Category

Kaiser Permanente Targets 5% of Worldwide Volunteer Enrollment for Project Lightspeed COVID-19 Vaccine Trial

Ranked as the 18th largest healthcare system in the United States, Kaiser Permanente isn’t afraid of ambitious targets as its’ California-based research organizations are no exception, raising the bar by planning to enroll up to 5% of all study participants...

UC Davis Health Ramps Up Project Lightspeed: Serves as Trial Site for Phase 2/3 BNT162 COVID-19 Vaccine Study

UC Davis Health was one of about 120 trial sites selected worldwide to participate in the Phase 2/3 stage testing of the COVID-19 vaccine candidate known as BTN162, developed by Germany’s BioNTech and Pfizer Inc. The addition of this pivotal clinical trial adds even a...

Upstate Medical University Selected by “Project Lightspeed” & Treats First Four Patients with BNT162 COVID-19 Vaccine

Upstate Medical University was selected by the Pfizer and BioNTech partnership to participate in the Phase 3 clinical trial assessing the safety and efficacy of the German company’s BNT162 vaccine targeting the novel coronavirus. Four vaccines in the BNT162 portfolio,...

Pin It on Pinterest